Pharma & Biotech

The investment thesis for Cytokinetics is gaining substantial momentum following compelling clinical trial results for its lead cardiac drug candidate,...

While the broader healthcare sector contends with regulatory pressures and shifting post-pandemic dynamics, Abbott Laboratories continues to demonstrate notable resilience....

The animal health leader Zoetis finds itself at a critical juncture, caught between compelling fundamental performance and emerging technical concerns....

A notable divergence has emerged in the trading activity surrounding biotech firm Incyte. The stock is climbing toward new peaks,...

Cellectar Biosciences is navigating a period of significant activity, marked by substantial advancements within its radiopharmaceutical pipeline and an enhanced...

Tobacco giant Altria may secure a significant competitive advantage in the rapidly expanding nicotine pouch market. In an unusual regulatory...

Investors seeking to lead a securities class action against Capricor Therapeutics must file their motions by September 15. This legal...

Shares of Danish pharmaceutical giant Novo Nordisk experienced continued pressure on Friday, puzzling observers who expected a positive market response...

Investors in French vaccine developer Valneva have experienced a period of extreme volatility, witnessing both significant setbacks and encouraging developments...

BioNTech has achieved a critical milestone in its oncology program, marking a significant advancement beyond its COVID-19 vaccine business. The...